We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stago's Headquarters Move to New Building

By LabMedica International staff writers
Posted on 22 Apr 2014
Hemostasis specialist Stago (Asnières sur Seine, France) has moved its headquarters to a new building fully dedicated to its business activities. The functional, and contemporary 8,300 m² building is designed to accommodate not only the Group’s various global functions but also the activities of its French subsidiary. It will allow the company to optimize its everyday operations and to greet partners and customers in an even more welcoming environment.

Officially recognised as a low-energy, high environmental quality building, this development is part of a sustainable quality approach embodying the values that have guided Stago for nearly 70 years. This investment is an indicator of the company’s healthy balance sheet. It was made possible by its employees’ expertise and hard work, and above all by the strong support of the hemostasis scientific and medical community.

Image: Stago\'s New Building (Photo courtesy of Stago).
Image: Stago\'s New Building (Photo courtesy of Stago).

Patrick Monnot, deputy vice president Stago, commented, “The rapid acceleration in our international expansion meant we needed a new Head Office, more closely reflecting the Stago image and its operations today.”

Related Links:

Stago



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Portable POCT Blood Gas Analyzer
BD100
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
22 Apr 2014  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
22 Apr 2014  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
22 Apr 2014  |   Industry